Recurrent HCC patients present significantly higher ratio Tim-3+ CD4+ T cells and Tim-3+CD8+ T cells in PBMCs before and after liver resection than non-recurrent HCC patients. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.